MENU
+Compare
ZTS
Stock ticker: NYSE
AS OF
Apr 1, 04:59 PM (EDT)
Price
$161.95
Change
-$2.70 (-1.64%)
Capitalization
77.48B

ZTS ZOETIS Forecast, Technical & Fundamental Analysis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more

ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ZTS with price predictions
Mar 31, 2025

ZTS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 13, 2025

ZTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 31 cases where ZTS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ZTS just turned positive on March 27, 2025. Looking at past instances where ZTS's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZTS advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 287 cases where ZTS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ZTS as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ZTS moved below its 50-day moving average on March 11, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ZTS crossed bearishly below the 50-day moving average on March 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.314) is normal, around the industry mean (60.617). P/E Ratio (32.943) is within average values for comparable stocks, (90.174). Projected Growth (PEG Ratio) (2.871) is also within normal values, averaging (2.987). Dividend Yield (0.009) settles around the average of (0.122) among similar stocks. P/S Ratio (9.033) is also within normal values, averaging (20.094).

View a ticker or compare two or three
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ZTS is expected to report earnings to $1.41 per share on May 06

ZOETIS ZTS Stock Earnings Reports
Q1'25
Est.
$1.41
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.03
The last earnings report on February 13 showed earnings per share of $1.40, beating the estimate of $1.38. With 2.25M shares outstanding, the current market capitalization sits at 77.48B.
A.I.Advisor
published Dividends

ZTS paid dividends on March 04, 2025

ZOETIS ZTS Stock Dividends
А dividend of $0.50 per share was paid with a record date of March 04, 2025, and an ex-dividend date of January 21, 2025. Read more...
A.I. Advisor
published General Information

General Information

a pet medication company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VITL30.470.75
+2.52%
Vital Farms
VRAR1.160.01
+0.87%
Glimpse Group (The)
DECK111.810.25
+0.22%
Deckers Outdoor Corp
CAMT58.63-0.37
-0.63%
Camtek Ltd
DSGN3.86-0.35
-8.31%
Design Therapeutics

ZTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with SNDL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.94%
SNDL - ZTS
33%
Loosely correlated
-2.76%
ACET - ZTS
31%
Poorly correlated
-9.06%
HLN - ZTS
29%
Poorly correlated
+0.49%
EVO - ZTS
27%
Poorly correlated
+0.91%
MKKGY - ZTS
25%
Poorly correlated
-2.94%
More